Recordati Posts 2021 Sales Rise As Market Recovers
Executive Summary
Italy's Recordati attributed a solid rise in OTC sales in 2021 to the recovery of the European market as the COVID-19 pandemic loosened its grip.
You may also be interested in...
Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
Recordati Launches Fortacin OTC In Germany Following EU-Wide Switch
Men in Germany can now purchase premature ejaculation treatment Fortacin without a prescription as a result of the EU-wide switch of the drug earlier this year.
Euro Q1 Consumer Health Earnings Preview: Reckitt, Sanofi, Haleon, Bayer
Major Europe-based consumer health players Reckitt, Sanofi, Haleon and Bayer feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q1 2024 results over the coming weeks.